Due to the challenge of performing metabolic tracing experiments in vivo, particularly in stromal cells that constitute a small proportion of the tumour, we have not validated in vivo whether, as in vitro, PDC activity is a major source of acetyl-CoA in CAFs. The gene discussed is PDC; the disease is neoplasm.